Delivers that enable cryotherapy-based endometrial treatments via compact, clinician-inspired handheld devices for comfortable office care.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Channel Medsystems designs and delivers handheld medical solutions that offer in-office treatments for heavy menstrual bleeding using cryotherapy. Its Cerene device merges innovative cooling technology with a user-friendly, self-contained format—ideal for comfortable, accessible care without reliance on large equipment. The approach reimagines women’s health interventions through simplicity, comfort, and clinician-informed engineering.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Cerene Management Team
Investors
Aperture Venture Partners LLC
Boston Scientific Corp
Incube Ventures LLC
Longwood Fund
Scientific Health Development
Third Point Ventures
Cerene Valuations & Financials
View real-time NPM data on Cerene stock including daily Cerene stock price estimates, valuation history, and historical share price information. Access Cerene financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Cerene pricing across six independent market signals. Looking for private company due diligence data sources on Cerene? Get in touch to learn more.
Similar Companies
like Cerene
NOCD
Healthcare & Life Sciences
A digital health company that provides evidence-based treatment for obsessive-compulsive disorder (OCD) through a virtual platform.
Arima Genomics
Healthcare & Life Sciences
Maps how DNA folds within cells to reveal structural insights driving genome analysis and disease discovery tools.
NEOK Bio
Healthcare & Life Sciences
Develops bispecific ADC therapies that target two distinct antigens to enhance tumour selectivity and therapeutic impact.
Mitra Bio
Healthcare & Life Sciences
Offers non-invasive skin diagnostics analyzing DNA methylation to assess skin health and aging.
Alessa Therapeutics
Healthcare & Life Sciences
Develops implantable drug-delivery systems that release targeted anti-androgen therapies to improve precision and minimize side effects.
Abpro
Healthcare & Life Sciences
Develops advanced biomedical engineering solutions, combining robotics and AI to enhance medical equipment and improve healthcare treatments.
FastWave Medical
Healthcare & Life Sciences
Develops intravascular lithotripsy systems for calcific artery disease, focusing on procedural efficiency and improved patient care.
Sequencing.com
Healthcare & Life Sciences
Empowers users to analyze and interpret genetic data using tools that convert DNA information into actionable health insights.
Calviri
Healthcare & Life Sciences
Provides multi‑cancer early detection and low‑cost vaccines to prevent or treat tumors.
FAQ
We have answers
Cerene stock does not trade on public stock exchanges. Cerene stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Cerene stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Cerene Stock does not trade on public stock exchanges. In order to sell Cerene shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Cerene does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Cerene share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Cerene stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Cerene stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Cerene stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Cerene is a private company and has not had an IPO. There is currently no Cerene IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Cerene IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
